19-04-2017 | Melanoma | Highlight | Article
Surgical resection still important in abdominal melanoma metastases
Patients who undergo surgical resection of abdominal visceral melanoma metastases have significantly better overall survival than those who do not, and the outcome is not greatly improved by modern systemic treatments, study findings indicate.
JAMA Surg 2017; Advance online publication
14-03-2017 | Melanoma | News | Article
Binimetinib extends NRAS-mutated metastatic melanoma PFS
Binimetinib could be incorporated into the treatment pathway of patients with advanced melanoma harboring NRAS mutations, say researchers who found a progression-free survival benefit with the MEK inhibitor over dacarbazine.
Lancet Oncol 2017; Advance online publication
03-11-2016 | Melanoma | News | Article
Melanoma survival extension with adjuvant ipilimumab comes at toxicity cost
Updated phase III trial results show that ipilimumab treatment improves overall survival and distant metastasis-free survival in stage III melanoma patients who have undergone complete resection, but with increased toxicity relative to placebo.
N Engl J Med 2016; Advance online publication; ESMO 2016; Copenhagen, Denmark
surgery11, IV drip_patient's hand/© sippakorn yamkasikorn / iStock / Thinkstock, Pregnant woman_grey background/© viktoriagavril / fotolia.com, lung_cancer, surgery11, IV drip_patient's hand/© sippakorn yamkasikorn / iStock / Thinkstock, Consultation_doctor_patient_mother/© michaeljung - Fotolia, Three way blank white sign/© MP - Fotolia, Man in scanner/© emirkoo / Fotolia, Male patient_doctor/© endostock / fotolia.com, doctor_patient1